Monthly Prescribing Reference

Dextenza Approved for Ocular Pain Following Ophthalmic Surgery

The approval was based on data from 2 vehicle-controlled Phase 3 trials. The Food and Drug Administration (FDA) has approved Dextenza (dexamethasone ophthalmic insert; Ocular Therapeutix) for the ...
Monthly Prescribing Reference

Dexamethasone Intracanalicular Insert Well-Retained Following Cataract Surgery

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, ...
Business Wire

Ocular Therapeutix Announces Third Medicare Administrative Contractor to Establish New Published Physician Fee Schedule for Administration of Intracanalicular Inserts

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...
Business Wire

Ocular Therapeutix™ To Present Clinical Data at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...
Healio

New steroid options allow surgeons to better tailor postoperative treatment

Please provide your email address to receive an email when new articles are posted on . With four new steroid options on the market to treat pain and inflammation after ocular surgery, ...
Healio

Manage cataract surgery pain to reduce postop discomfort, patient responsibility

Please provide your email address to receive an email when new articles are posted on . WAIKOLOA, Hawaii — Reducing intraoperative inflammation and anxiety through medications and calming techniques ...